Pain Therapeutics (PTIE)

Add to Watchlists Create an Alert
3.79 -0.07  -1.81% NASDAQ Sep 17, 5:00PM BATS Real time Currency in USD
View Full Chart
PTIE Price Chart
View All Events

PTIE Events

Date Type Description
08/05/2014 16:30 EDT Misc Pain Therapeutics Inc Q2 2014 Earnings Conference Call
08/05/2014 Earnings Pain Therapeutics Inc Q2 2014 Earnings Results
05/16/2014 Misc Annual General Meeting for Pain Therapeutics Inc
05/06/2014 16:30 EDT Misc Pain Therapeutics Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings Pain Therapeutics Inc Q1 2014 Earnings Results
02/04/2014 16:00 CDT Misc Pain Therapeutics, Inc. 4Q2013 Earning Conference Call
02/04/2014 Earnings Pain Therapeutics, Inc. 4Q2013 Earning Result
02/04/2014 Misc Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014
10/31/2013 Earnings Pain Therapeutics Reports Q3 2013 Financial Results
View All Performance Charts

PTIE Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pain Therapeutics is up 43.56% over the last year vs S&P 500 Total Return up 20.37%, ARCA biopharma down 3.65%, and Xencor up N/A.

Get Quote for

Portfolio Strategies Featuring PTIE

Did Pain Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PTIE Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Pain Therapeutics, Inc., is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.

PTIE Excel Add-In Codes

  • Name: =YCI("PTIE","name")
  • Description: =YCI("PTIE","description")
  • Sector: =YCI("PTIE","sector")
  • Industry: =YCI("PTIE","industry")
  • Est. Current Fiscal Year End: =YCI("PTIE","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start your {{}} Membership


{{ ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{}} Member? Sign in here.